AXON - アクソバント・サイエンシズ (Axovant Sciences Ltd.) アクソバント・サイエンシズ



symbol AXON
会社名 Axovant Sciences Ltd (アクソバント・サイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アクソバント・サイエンシズ(Axovant Sciences Ltd.)は臨床段階のバイオ医薬品会社である。同社はアルツハイマー病およびレヴィー小体認知症を含む認知症の治療薬の獲得・開発・商業化を行う。同社は認知症および関連する神経学的障害の認知的、機能的および行動的側面に対処するための製品候補のパイプラインを開発する予定である。同社はアルツハイマー病およびレビー小体(DLB)による認知症を治療するために、選択的5-ヒドロキシトリプタミン6受容体アンタゴニストであるリード製品候補のインジパルジンを開発する。また、DLB患者における急速眼球運動障害(REM)行動障害およびレヴィー小体認知症の患者における視覚幻覚の治療用、選択的5-ヒドロキシトリプタミン2A受容体インバースアゴニストであるネロタンセリンを開発する。同社のパイプラインには、RVT-103とRVT-104が含まれる。   アクソバント・サイエンシズは、バミュ―ダの臨床段階バイオ医薬品会社。主に、アルツハイマ―型認知症治療薬「RVT-101」の開発と商業化に焦点を当てる。「RVT-101」は、セロトニン5-HT6受容体アンタゴニストで、認知障害の治療に向けた新薬として注目される。本社はバミュ―ダの首都ハミルトン。   Axon is a network of devices, apps and people that helps public safety personnel become smarter and safer. With a mission of protecting life, its technologies give customers the confidence, focus and time they need to keep their communities safe. Its products impact every aspect of a public safety officer's day-to-day experience with the goal of helping everyone get home safe.
本社所在地 11-12 St. James's Square Suite 1 3rd Floor London SW1Y 4LB GBR
代表者氏名 Pavan Cheruvu パヴァン・チェルーヴ
代表者役職名 Chief Executive Officer Director 最高経営責任者(CEO)
電話番号 +44 1295-5950
設立年月日 41913
市場名 NYSE(ニューヨーク証券取引所)
ipoyear ―年
従業員数 69人
EBITDA EBITDA(百万ドル) -193.47800
終値(lastsale) 2.04
時価総額(marketcap) 249044807.52
時価総額 時価総額(百万ドル) 268.57770
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 228.68170
当期純利益 当期純利益(百万ドル) -204.19500
決算概要 決算概要 BRIEF: For the three months ended 30 June 2018 Axovant Sciences Ltd revenues was not reported. Net loss decreased 25% to $51.9M. Lower net loss reflects Stock-based Compensation in SGA decrease of 64% to $3.3M (expense) General and administrative (includes $14 decrease of 31% to $8.4M (expense) Stock-based Compensation in R&D decrease of 60% to $2.5M (expense).



   GovTech Market Outlook 2021 | Covid19 Impact Analysis | Growth by Top Companies: APPCityLife, Acivilate, Axon, Rachio, Airboxlabs  2021/07/16 13:49:59 Tramways Monthly
GovTech Market describes an in-depth evaluation and Covid19 Outbreak study on the present and future state of the GovTech market across the globe, including valuable facts and figures. GovTech Market provides information regarding the emerging opportunities in the market & the market drivers, trends & upcoming technologies that will boost these growth trends. The report []
   Virginia Beach PD Latest MCCA Member to Join the Axon Network  2021/07/16 11:30:00 PR Newswire
SCOTTSDALE, Ariz., July 16, 2021 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies today announced that the Virginia Beach Police Department has signed a 10-year contract with Axon to deploy TASER 7 energy weapons and body-worn cameras as a
   Why Axon''s Shares Jumped 25.8% in June  2021/07/05 19:21:00 The Motley Fool
Growth stocks are back!
   Axon and DroneSense Partner to Bring State-of-the-Art Situational Awareness and UAS Management Software to Public Safety  2021/07/02 19:15:00 Intrado Digital Media
Strategic partnership will help public safety Unmanned Aircraft Systems (UAS) users effectively manage data and evidence Strategic partnership will help public safety Unmanned Aircraft Systems (UAS) users effectively manage data and evidence
   WRAP Appoints Public Safety Technology Executive Glenn Hickman as Chief Operating Officer  2021/07/02 19:00:56 Benzinga
Former Axon Enterprises product leader to continue advancing BolaWRAP family of products Elwood "Woody" Norris retiring from CTO Role, remain as strategic consultant TEMPE, Ariz., July 02, 2021 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (the "Company" or "WRAP") (NASDAQ: WRAP ), a global leader in innovative public safety technologies and services, announced the appointment of Glenn Hickman as Chief Operating Officer. Hickman will work closely with the growing engineering and operations teams to continue building out WRAP''s product lines. Woody Norris, inventor of the BolaWRAP, retired as CTO at the end of June and will continue to play an active role at WRAP as a strategic consultant focusing on new innovations. Hickman is a proven executive with extensive research and development, supply chain, manufacturing, and software engineering experience. Hickman worked at Axon Enterprises (formerly TASER International) from 2011-2019, serving as Vice President of Research and Development from 2014-2019.
   Axovant: Fiscal Q4 Earnings Snapshot  2021/06/09 11:19:54 CityNews Toronto
NEW YORK (AP) _ Axovant Sciences Ltd. (SIOX) on Wednesday reported a loss of $3.3 million in its fiscal fourth quarter. On a per-share basis, the New York-based company said it had a loss of 5 cents. Losses, adjusted for non-recurring gains, came to 19 cents per share. The results fell short of Wall Street []
   Axon: Feel The Thunder  2021/06/06 19:20:19 Seeking Alpha
   Global Idelalisib(CAL-101) Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027  2021/05/20 18:30:00 Ken Research
The global Idelalisib(CAL-101) market is expected to reach USD XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: TCI Axon Medchem Focus Biomolecules Biosynth Carbosynth Enzo Biochem BOC Sciences Santa Cruz Biotechnology Selleck Chemicals Adooq Bioscience BioVision Aladdin Clearsynth Cayman Chemical Shimadzu LGC LKT Laboratories By Types: Min Purity Less Than 98% Min Purity 98%-99% Min Purity More Than 99% By Applications: Research Medical Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market''s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
   Robust Growth Catalysts Don''t Justify Axon''s Recent Selloff  2021/05/19 19:49:26 Seeking Alpha
   NorthCoast Asset Management LLC Buys FedEx Corp, Facebook Inc, U.S. ...  2021/05/19 17:38:07 GuruFocus
Related Stocks: FDX , FB , CFG , MUB , QCOM , PBR , USB , PII , EWU , VNQ , AXON , FNCL ,
   Axon: Feel The Thunder  2021/06/06 19:20:19 Seeking Alpha

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アクソバント・サイエンシズ AXON Axovant Sciences Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)